#Accuray #Austria #CyberKnife #Salzburg

Accuray Launches CyberKnife® Treatments in Austria

Accuray Incorporated, a leader in precision radiation therapy, has made a significant move in expanding cancer treatment options in Austria by announcing that the CyberKnife Center Salzburg is the first facility in the country to utilize the cutting-edge CyberKnife® System for treating patients. This groundbreaking approach incorporates stereotactic radiosurgery (SRS) and ultra-hypofractionated stereotactic body radiation therapy (SBRT), known for their extremely high precision and accuracy.

A Game-Changer for Cancer Treatment

The introduction of the CyberKnife System in Austria is poised to revolutionize cancer treatment. With the ability to deliver high doses of radiation in just one to five outpatient sessions instead of the traditional 30 to 40, patients can expect both effective treatment and significantly reduced hospital visits. This is particularly beneficial for patients unable to commit to prolonged treatment schedules, allowing quicker access to vital care.

The CyberKnife Center Salzburg's medical team effectively halved the commissioning time necessary to initiate operations by using the innovative Accuray CyberComm™ technology. This efficiency enables them to commence patient treatments promptly, showcasing a commitment to advancing cancer care in the region.

The Efficacy of Ultra-Hypofractionation

Recent studies indicate that ultra-hypofractionation results in outcomes comparable to conventional treatments while significantly lowering the treatment burden on patients. Seth Blacksburg, M.D., the Chief Medical Officer at Accuray, emphasized the increasing acceptance of this treatment modality, noting that more oncologists are choosing the CyberKnife® System to enhance treatment efficiency and effective patient care.

Suzanne Winter, president and CEO of Accuray, also underlined the importance of providing healthcare teams with cutting-edge technologies that lead to better patient outcomes. She expressed enthusiasm for collaborating with the CyberKnife Center Salzburg in its mission to enhance cancer care accessibility and quality.

Addressing Austria’s Cancer Care Needs

Looking at the broader picture, the incidence of cancer in Austria is projected to increase by nearly 25% by 2040. Despite Austria's high ratings for oncology medication reimbursement, the availability of radiotherapy equipment lags behind the European Union average. With established reports indicating that Austria's supply is 27% below the EU standards, the adoption of advanced systems like the CyberKnife is essential to addressing these gaps and improving patient care.

Dr. Alfred Haidenberger from the CyberKnife Center Salzburg expressed his dedication to bringing advanced cancer treatment options to Austria. He highlights that the CyberKnife System stands out for its high-dose delivery parallel to the patient's condition, ensuring they receive timely and effective care. The system's ability to streamline treatment reduces the strain of lengthy sessions on patients and substantially enhances their overall quality of life.

This innovation in radiation therapies promises not only to improve survival rates but to allow individuals the chance to enjoy important moments in their lives, free from the burdensome schedule of traditional cancer treatments.

As Accuray continues to lead in the field of radiation therapy, the focus remains on innovation and patient-centered care, which ultimately benefits both clinicians and those they serve. The CyberKnife System symbolizes hope for better cancer treatment pathways in Austria and beyond, fostering an environment where more patients can access efficient and precise therapies tailored to their needs.

For further information about this pioneering technology and its impact, visit Accuray.org.